Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NRX Pharmaceuticals, Inc. | 50,000 | reported | 09 Apr 2025 | tx 12+2,042,438 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Apr 2025 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 2,500 | 1.25 USD | |
| 28 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 1,750 | 1.25 USD | |
| 28 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 2,500 | 1.24 USD | |
| 28 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 2,500 | 1.25 USD | |
| 28 Nov 2022 | PURCHASE | NRX Pharmaceuticals, Inc. | 2,500 | 1.25 USD | |
| 21 Oct 2022 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 162,660 | — | deriv |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 35,209 | — | |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 35,209 | — | |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 362,332 | — | |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 692,639 | — | deriv |
| 24 May 2021 | GRANT_AWARD | NRX Pharmaceuticals, Inc. | 692,639 | — | deriv |